ClinConnect ClinConnect Logo
Search / Trial NCT06892184

Importance of the Type of Communication Used During Paraapical Anesthesia in Dentistry

Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Mar 21, 2025

Trial Information

Current as of April 26, 2025

Not yet recruiting

Keywords

Therapeutic Communication Dental Care Induced Pain Nocebo Effect Hypnosis

ClinConnect Summary

This clinical trial is exploring how different ways of communicating with patients can affect their experience of pain and anxiety during a common dental procedure called para-apical anesthesia, which is used to numb an area of the mouth for treatment. The researchers want to find out if using positive and calming language (referred to as hypnotic communication) works better than traditional methods that often mention pain beforehand. This is important because many people feel anxious about dental visits, and improving communication could help make the experience more comfortable for patients.

To be eligible for this trial, participants need to be over 18 years old and require para-apical anesthesia for dental care. They should also be able to understand French and provide written consent to join the study. During the trial, participants will be asked about their anxiety and comfort levels before and after the anesthesia, as well as their pain experience. This study aims to provide insights that could improve dental practices and help future dentists communicate better with their patients, ultimately enhancing their care and comfort during dental procedures.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male or female patient over 18 years of age requiring para-apical anesthesia for dental care.
  • Patient informed of the constraints of the study and having given written consent.
  • Patient covered by social security.
  • Patient with a good command of French.
  • Exclusion Criteria:
  • Pregnant or breastfeeding women, or women who may become pregnant.
  • Patients under 18 years of age.
  • Patients presenting to the department in an emergency situation (which may increase stress).
  • Any medical condition deemed by the investigator to be incompatible with the study.
  • Known hypersensitivity to amide-bonded local anesthetics or to any of the excipients.
  • Anticoagulant treatment or known blood crase disorders.
  • Porphyrias.
  • Atrioventricular conduction disorders requiring permanent electrosystolic training not yet performed.
  • Epilepsy not controlled by treatment.
  • Patient uncooperative, unable to speak or read French fluently, unable to understand the principle of a pain scale, unable to understand the study or unable to sign informed consent.
  • Patients under guardianship, curatorship or deprived of liberty.
  • Patients premedicated with anxiolytics
  • Care requiring anesthesia other than para-apical anesthesia
  • Patient highly anxious about dental treatment (Score ≥15 on Corah scale)

About University Hospital, Clermont Ferrand

The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.

Locations

Clermont Ferrand, , France

Patients applied

0 patients applied

Trial Officials

Céline Melin

Principal Investigator

University Hospital, Clermont-Ferrand

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported